132 related articles for article (PubMed ID: 11007248)
1. Algorithm for the treatment of Crohn's disease: incorporation of emerging therapies.
Souney PF
Am J Gastroenterol; 2000 Sep; 95(9):2381-3. PubMed ID: 11007248
[No Abstract] [Full Text] [Related]
2. Treatment of Crohn's disease at the turn of the century.
Bickston SJ; Cominelli F
N Engl J Med; 1998 Aug; 339(6):401-2. PubMed ID: 9691110
[No Abstract] [Full Text] [Related]
3. [Drug therapy of inflammatory bowel diseases].
Silvennoinen J; Niemelä S
Duodecim; 1999; 115(20):2233-8. PubMed ID: 11973927
[No Abstract] [Full Text] [Related]
4. Chimeric monoclonal antibody cA2 to tumor necrosis factor alpha for Crohn's disease.
Bauditz J; Lochs H; Schreiber S
N Engl J Med; 1998 Jan; 338(5):334. PubMed ID: 9446035
[No Abstract] [Full Text] [Related]
5. Treatment of vulval Crohn's disease with infliximab.
Preston PW; Hudson N; Lewis FM
Clin Exp Dermatol; 2006 May; 31(3):378-80. PubMed ID: 16681581
[TBL] [Abstract][Full Text] [Related]
6. [From research to clinic: The case of Crohn's disease and Tumor Necrosis Factor].
Pellicano R
Minerva Gastroenterol Dietol; 2000 Jun; 46(2):131-8. PubMed ID: 19320082
[No Abstract] [Full Text] [Related]
7. Longstanding Crohn's vulvitis successfully treated with combined anti-TNFα antibody and azathioprine.
Macdonagh E; Pugh S; Fox R
J Obstet Gynaecol; 2013 Jul; 33(5):530. PubMed ID: 23815219
[No Abstract] [Full Text] [Related]
8. [Biological drugs in inflammatory bowel disease. Valuable supplement--but only when conventional therapy is not sufficient].
Hellström PM; Schmidt D; Karlén P
Lakartidningen; 2007 Oct 10-16; 104(41):2973-6. PubMed ID: 17977308
[No Abstract] [Full Text] [Related]
9. Case report: combination therapy with granulocyte apheresis and infliximab for refractory Crohn's disease.
González Carro P; Pérez Roldán F; Roncero García Escribano O; Lafuente R; Legaz Huidobro ML; Amigo Echenagusía A
J Clin Apher; 2006 Dec; 21(4):249-51. PubMed ID: 16607627
[No Abstract] [Full Text] [Related]
10. [Drug therapy of Crohn disease].
Niemelä S
Duodecim; 2001; 117(8):807-14. PubMed ID: 12116446
[No Abstract] [Full Text] [Related]
11. Aminosalicylates for active disease and in the maintenance of remission in Crohn's disease.
Feagan BG
Eur J Surg; 1998 Dec; 164(12):903-9. PubMed ID: 10029385
[No Abstract] [Full Text] [Related]
12. Treatment of fistulizing Crohn's disease.
Judge TA; Lichtenstein GR
Gastroenterol Clin North Am; 2004 Jun; 33(2):421-54, xi-xii. PubMed ID: 15177547
[TBL] [Abstract][Full Text] [Related]
13. Prediction of response to infliximab in Crohn's disease.
Chaudhary R; Ghosh S
Dig Liver Dis; 2005 Aug; 37(8):559-63. PubMed ID: 15893967
[No Abstract] [Full Text] [Related]
14. Managing complicated Crohn's disease in children and adolescents.
Homan M; Baldassano RN; Mamula P
Nat Clin Pract Gastroenterol Hepatol; 2005 Dec; 2(12):572-9. PubMed ID: 16327836
[TBL] [Abstract][Full Text] [Related]
15. Adalimumab: new indication. Severe Crohn's disease: a second TNF alpha antagonist, subcutaneous administration.
Prescrire Int; 2008 Aug; 17(96):137. PubMed ID: 19480092
[No Abstract] [Full Text] [Related]
16. Maintenance of medically induced remission of Crohn's disease.
Gonvers JJ; Juillerat P; Mottet C; Pittet V; Felley C; Vader JP; Michetti P; Froehlich F
Digestion; 2007; 76(2):116-29. PubMed ID: 18239403
[TBL] [Abstract][Full Text] [Related]
17. [What can be expected from biological therapies for Crohn's disease?].
Lemann M
Gastroenterol Clin Biol; 2001 Nov; 25(11):945-7. PubMed ID: 11845043
[No Abstract] [Full Text] [Related]
18. Medical therapy for refractory pediatric Crohn's disease.
Faubion WA; Bousvaros A
Clin Gastroenterol Hepatol; 2006 Oct; 4(10):1199-213. PubMed ID: 16872913
[TBL] [Abstract][Full Text] [Related]
19. Long-term partial remission of autoimmune thrombocytopenia in a patient treated with the anti-tumor necrosis factor-alpha antibody infliximab for refractory fistulizing Crohn's disease.
de Rossi TM; Krauss N; Voll RE; Nägel A; Weidenhiller M; Konturek PC; Hahn EG; Raithel M
Digestion; 2008; 78(4):195-200. PubMed ID: 19122456
[TBL] [Abstract][Full Text] [Related]
20. Anti-tumour necrosis factor-alpha therapies in Crohn's disease.
Sprakes MB; Hamlin PJ
Br J Hosp Med (Lond); 2009 Nov; 70(11):644-7. PubMed ID: 20081592
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
